TrialLeukemia2019
CD22 CAR T-cell therapy in refractory or relapsed B acute lymphoblastic leukemia.
Jing Pan et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
146 papers cite itlatest 60 shown
this paperpooled ittrialcites it
TrialLeukemia2019
Jing Pan et al.PubMed ↗Publisher ↗
No numbers read from the abstract.